The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genome-based outcome prediction in MYCN nonamplified high-risk neuroblastoma.
Andres Eduardo Morales La Madrid
No relevant relationships to disclose
Thomas Stricker
No relevant relationships to disclose
Peter Pytel
No relevant relationships to disclose
Yasmin C. Gosiengfiao
No relevant relationships to disclose
Jason Shohet
No relevant relationships to disclose
Hiroyuki Shimada
No relevant relationships to disclose
Wayne Lee Furman
No relevant relationships to disclose
Peter E. Zage
No relevant relationships to disclose
Julie R. Park
No relevant relationships to disclose
Elizabeth Perlman
No relevant relationships to disclose
Lisa Guerrero
No relevant relationships to disclose
Helen Salwen
No relevant relationships to disclose
Alexandre Chlenski
No relevant relationships to disclose
Wendy B. London
No relevant relationships to disclose
Susan Lerner Cohn
No relevant relationships to disclose